NasdaqGS:ANABBiotechs
AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading
AnaptysBio (ANAB) has drawn renewed attention after recent trading left the stock at a last close of $57.61. The company’s clinical-stage immunology portfolio and collaborations are in focus for investors.
See our latest analysis for AnaptysBio.
Recent trading has been choppy for AnaptysBio, with the share price slipping 3.19% over the last day and also down over the past month and quarter, yet supported by a 28.16% year to date share price return and a very large 1 year total shareholder...